?
For this product, a doctors prescription is required. Please do not forget to attach a copy of your valid prescription (.jpeg,bmp, gif, jpg, jpeg, jpe, jif, jfif,
jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription.
Please present the original copy of your prescription upon the arrival of your order.
?
?
?
?
Brand Name
Adeflo MDI
Generic Name
Salmeterol + Fluticasone
Strength
Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg
Dosage Form
Metered Dose Inhaler
Class Name
Antiasthmatic & COPD Preparations
Indication/Usage
Regular treatment of asthma where use of a combination product (long-acting ?2-agonist & inhaled corticosteroid) is appropriate:?
?
Patients not adequately controlled w/ inhaled corticosteroids & as needed inhaled short acting ?2-agonist; already adequately controlled on
?
both inhaled corticosteroids & long-acting ?2-agonist.
?
?
Dosage and Administration
Salmeterol and Fluticasone Propionate Pressurized Inhalation CFC Free inhaler is for inhalation use only.
?
Patients should be regularly reassessed by a doctor, so that the strength of Salmeterol and Fluticasone Propionate Pressurized Inhalation?
?
CFC Free inhaler they are receiving remains optimal and is only changed on medical advice.?
?
Recommended Doses: Adults and adolescents 12 years and older:
?
two inhalations of 25 micrograms Salmeterol and 125 micrograms Fluticasone propionate twice daily.
?
?
Warning and Precautions
Pulmonary TB. Do not use to treat acute asthma symptoms for which fast & short-acting bronchodilator is required.?
?
Do not initiate during exacerbation or significantly worsening or acutely deteriorating asthma.?
?
Serious asthma-related adverse events & exacerbation; systemic effects (particularly childn & adolescents <16 yr at high doses) may occur.
?
Deterioration of asthma control (may be sudden & progressive). Rarely, cardiac arrhythmias eg, supraventricular tachycardia, extrasystoles &?
?
atrial fibrillation & mild transient reduction in serum K (high doses) may occur. Possible development of pneumonia & other lower resp tract?
?
infections in patients w/ COPD. Reduce dose gradually once symptoms are controlled. Transferring intake from oral to inhalation.
?
Prolonged treatment. Concomitant use w/ ritonavir; systemic ketoconazole or other potent CYP34 inhibitors.
?
Pregnancy & lactation. Childn <4 yr.
Contraindication
Hypersensitivity.
Requires prescription?
Yes
Storage Conditions
Store at temperatures not exceeding 30?C. Do not freeze.
Manufacturer
Glenmark Philippines, Inc.
Regulatory Classification
RX (Prescription Required )



































